MedTrace Logo

Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue

NCT00909350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-02-12

No results posted yet for this study

Summary

This is a laboratory-based, exploratory study using tissue obtained from our clinical practice. The purpose of this study is to confirm our ability to characterize miR expression in various tissues (proximal and distal esophagus, stomach and duodenum) obtained from the upper gastrointestinal tract in preparation for the study of MiR in patients with Barrett's esophagus and other inflammatory conditions of the upper gastrointestinal tract.

Conditions

  • Barrett's Esophagus
  • Esophageal Adenocarcinoma

Sponsors & Collaborators

Principal Investigators

  • Kenneth R. DeVault,, M.D. · Mayo Clinic, Jacksonville, Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00909350 on ClinicalTrials.gov